International Market Briefing

Monday, July 27, 2026 | 7:30 a.m.
Location: Anaheim Marriott (Marquis Ballroom) – Anaheim, CA, USA

Held in conjunction with ADLM 2026 (formerly AACC Annual Meeting & Clinical Lab Expo)

Register Now

Registration

Registration for ADLM 2026 is required to attend the International Market Briefing (IMB). The IMB is a ticketed special event, but there is no additional cost to attend.

• During registration, add the International Market Briefing (IMB) by selecting it in the session search under ticketed sessions.
• Select Conference Registration to access education sessions, the Clinical Lab Expo, and the IMB.
• Select Clinical Lab Expo if you plan to attend only the IMB and the Clinical Lab Expo.
• Already registered? Add the IMB through the Registration Resource Center.

Advance registration is required by Sunday, July 26. Attendees must obtain their official event badge in advance to gain entry.

If you have questions, please contact ADLM Customer Service at [email protected].

Learn about global IVD market trends

Join ADLM for the 2026 International Market Briefing & Financial Analyst Briefing, where global leaders in diagnostics come together to explore the latest trends shaping the in vitro diagnostics (IVD) market.

This program brings together international company executives and financial analysts to:

• Gain insights into key IVD market sectors and emerging trends
• Explore developments across global and emerging markets
• Connect and network with industry peers

Who should attend

This program is intended for international marketing executives, financial analysts, trade specialists, distributors, and others responsible for international marketing and sales.

Register Now

Program agenda

Monday, July 27, 2026 – Anaheim, CA, USA

7:30 – 8:15 a.m. | Networking Breakfast

8:15 – 8:20 a.m. | ADLM CEO Welcome & Opening Remarks

Melanie J. Wells, MPH, CAE
ADLM CEO

8:20 – 8:30 a.m. | ADLM Board President Welcome

Paul J. Jannetto, Ph.D., DABCC, FACB, M.T.(ASCP)
ADLM Board President

8:30 – 8:40 a.m. | Speaker Introductions

Kristin Pothier
Life Sciences Sector Leader, Global Deal Advisory and Strategy Leader, Healthcare and Life Sciences, KPMG, Boston, MA, USA

8:40 – 9:25 a.m. | Global IVD Market Update – IQVIA

Overview of worldwide IVD market trends.

Vladimir Nozinic
Engagement Manager, IQVIA MedTech IVD Solutions

Naveen Nath
Engagement Manager, IQVIA MedTech IVD Solutions

9:25 – 10:15 a.m. | Expanding Access in Diagnostics: The Evolving Role of Testing Across Settings

Diagnostic testing is rapidly expanding beyond the traditional lab into near-patient and home-based settings, creating new opportunities to improve access and patient reach. This panel discussion brings together perspectives from across the diagnostics ecosystem to explore how these models are developing in practice and how organizations are positioning for the next phase of growth.

Moderator: Mark Whitten, PhD
Managing Director, TriMar Strategies

10:15 – 10:30 a.m. | Networking Break

10:30 – 11:15 a.m. | AI in Diagnostics: Enhancing Testing & Workflow Performance

Explore how artificial intelligence is being applied to improve diagnostics, both within laboratories and across broader care settings.

Panelist: Nicholas (Nick) Spies, MD
Medical Director in Applied AI and Clinical Chemistry
Institute for Research and Innovation, ARUP Laboratories
Assistant Professor, Department of Pathology, University of Utah

Panelist: Mark Zaydman, MD, PhD
Associate Professor of Pathology and Immunology, Washington University School of Medicine in St. Louis

Moderator: Sarah Wheeler, PhD (she/her/hers)
Associate Professor, Department of Pathology
Director, Laboratory Medicine AI, Computational Pathology & AI Center of Excellence
Medical Director, Clinical Pathology, UPMC Children’s Hospital of Pittsburgh

11:15 – 11:45 a.m. | M&A Trends in IVD and Lab Testing

A fireside-style discussion on the latest mergers, acquisitions, and investment trends shaping the diagnostics industry.

Moderator: Jessica Lin
Partner, KPMG

11:45 a.m. – 12:00 p.m. | Closing Remarks

Kristin Pothier
Life Sciences Sector Leader, Global Deal Advisory and Strategy Leader, Healthcare and Life Sciences, KPMG, Boston, MA, USA